IL10 and COVID-19: However, our study identifies ferritin and IL-10 as pivotal biomarkers for predicting glucocorticoid responsiveness in severe COVID-19, addressing a critical gap highlighted by the RECOVERY trial’s subgroup heterogeneity (10).